Cargando…
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond
Hepatocellular carcinoma (HCC) has high mortality. The option of systemic therapy has increased significantly over the past five years. Sorafenib was the first multikinase inhibitor, introduced in 2007, as a treatment option for HCC, and it was the only effective systemic treatment for more than ten...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406660/ https://www.ncbi.nlm.nih.gov/pubmed/36005172 http://dx.doi.org/10.3390/curroncol29080434 |